We are live on ! Find out more
CLVS

Clovis Oncology, Inc.
CLVS

Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

229 hedge funds and large institutions have $2.8B invested in Clovis Oncology, Inc. in 2017 Q1 according to their latest regulatory filings, with 86 funds opening new positions, 77 increasing their positions, 55 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

406% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 17

66% more capital invested

Capital invested by funds: $1.68B → $2.8B (+$1.12B)

40% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 55

37% more funds holding

Funds holding: 167 → 229 (+62)

36% more call options, than puts

Call options by funds: $100M | Put options by funds: $73.6M

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

Holders
229
Holders Change
+62
Holders Change %
+37.13%
% of All Funds
5.7%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
86
Increased
77
Reduced
55
Closed
17
Calls
$100M
Puts
$73.6M
Net Calls
+$26.5M
Net Calls Change
-$240K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$185M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$80.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$80.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$56.1M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$49.5M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$84.9M
2
PC
PointState Capital
New York
-$69.7M
3
NMC
NEA Management Company
Maryland
-$50.6M
4
SC
Samlyn Capital
New York
-$40.1M
5
RG
Redmile Group
California
-$39.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
WMSA
126
Weiss Multi-Strategy Advisers
New York
$1.4M +$1.34M +22,000 New
PIM
127
Partner Investment Management
California
$1.39M -$229K -3,772 -15%
GH
128
GAM Holding
Switzerland
$1.39M +$1.33M +21,800 New
Victory Capital Management
129
Victory Capital Management
Texas
$1.36M +$1.29M +21,208 +11,464%
IBT
130
International Biotechnology Trust
United Kingdom
$1.27M -$3.34M -55,000 -73%
SGH
131
Sivik Global Healthcare
Connecticut
$1.27M +$304K +5,000 +33%
State Board of Administration of Florida Retirement System
132
State Board of Administration of Florida Retirement System
Florida
$1.27M -$122K -2,010 -9%
CEP
133
Chicago Equity Partners
Illinois
$1.24M +$24.3K +400 +2%
CIA
134
Capital Impact Advisors
Massachusetts
$1.24M +$1.18M +19,416 New
TCM
135
Timpani Capital Management
Wisconsin
$1.23M +$1.18M +19,350 New
BG
136
Bellevue Group
Switzerland
$1.18M -$91.2K -1,500 -8%
Jane Street
137
Jane Street
New York
$1.13M +$1.08M +17,694 New
1832 Asset Management
138
1832 Asset Management
Ontario, Canada
$1.12M +$1.07M +17,600 New
JCM
139
Jafra Capital Management
New York
$1.12M +$1.07M +17,615 New
CCMH
140
Cornerstone Capital Management Holdings
New York
$1.12M +$994K +16,344 +1,362%
DCM
141
Driehaus Capital Management
Illinois
$1.02M +$973K +15,998 New
CCP
142
Clough Capital Partners
Massachusetts
$1.01M +$6.08K +100 +0.6%
MIM
143
Monashee Investment Management
Massachusetts
$955K – – –
GL
144
GLG LLC
New York
$923K +$881K +14,496 New
SO
145
STRS Ohio
Ohio
$896K +$856K +14,079 New
Two Sigma Advisers
146
Two Sigma Advisers
New York
$885K +$845K +13,900 New
HMS
147
Hanseatic Management Services
New Mexico
$869K +$829K +13,637 +71,774%
Stifel Financial
148
Stifel Financial
Missouri
$825K -$2.31K -38 -0.3%
Legal & General Group
149
Legal & General Group
United Kingdom
$798K +$66.1K +1,087 +9%
TMAM
150
Tokio Marine Asset Management
Japan
$760K +$729K +11,988 New
4 5
6
7 8

CLVS Hedge Fund Activity: Q1 2017 in Review

229 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q1 2017, worth a combined $2.8B — up 66% from $1.68B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new CLVS positions and 17 closed out — a net gain of 69 holders — while 77 added to existing stakes and 55 trimmed.

The largest buyer was BlackRock, adding an estimated $185M. The largest seller was Consonance Capital Management, cutting an estimated $84.9M.

  • 229 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q1 2017, up from 167 in Q4 2016.
  • Funds reported $2.8B of Clovis Oncology, Inc. stock for Q1 2017, up 66% quarter-over-quarter.
  • 86 funds opened new Clovis Oncology, Inc. positions in Q1 2017 and 17 closed out, a net change of +69 holders.
  • The largest Clovis Oncology, Inc. buyer in Q1 2017 was BlackRock, an estimated $185M added.
  • The largest Clovis Oncology, Inc. seller in Q1 2017 was Consonance Capital Management, an estimated $84.9M sold.

Based on aggregated 13F filings for Q1 2017.